MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Intuitive Surgical Operating Expenses 2011-2026 | ISRG
Annual Operating Expenses Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.7 B | 3.29 B | 2.96 B | 2.62 B | 2.14 B | 1.81 B | 1.74 B | 1.4 B | 1.14 B | 945 M | 838 M | 869 M | 742 M | 692 M | 579 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.7 B | 579 M | 1.7 B |
Quarterly Operating Expenses Intuitive Surgical
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 975 M | - | 903 M | 874 M | 880 M | - | 797 M | 805 M | 776 M | - | 701 M | 709 M | 725 M | - | 653 M | - | 602 M | - | 529 M | 512 M | 486 M | - | 454 M | 422 M | 455 M | - | 420 M | 400 M | 417 M | - | 329 M | 355 M | 317 M | - | 288 M | 270 M | 276 M | - | 231 M | 226 M | 226 M | - | 206 M | 213 M | 206 M | - | 202 M | 201 M | 259 M | - | 182 M | 187 M | 183 M | - | 179 M | 161 M | 163 M | - | 147 M | 138 M | 130 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 975 M | 130 M | 417 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 62.55 | -0.48 % | $ 12.5 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Glaukos Corporation
GKOS
|
482 M | $ 120.23 | -13.52 % | $ 6.88 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
3.37 B | $ 67.78 | -0.22 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
779 M | $ 133.31 | 1.52 % | $ 3.28 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 116.56 | -1.11 % | $ 3.73 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 4.1 | -0.97 % | $ 189 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 97.75 | -1.78 % | $ 2.21 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.81 | 0.1 % | $ 9.53 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.38 | -1.77 % | $ 31.2 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 6.67 | 11.35 % | $ 56.6 K | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | - | - | $ 3.94 B | USA |
 |
Haemonetics Corporation
HAE
|
631 M | $ 65.49 | 5.73 % | $ 3.09 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.54 B | $ 216.57 | -1.41 % | $ 21.3 B | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 32.47 | -0.98 % | $ 1.61 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 9.66 | -2.82 % | $ 200 M | USA |
 |
Microbot Medical
MBOT
|
9.09 K | - | - | $ 78.3 M |  Israel |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 132.75 | 0.9 % | $ 5.92 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 64.51 | -0.74 % | $ 209 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 64.17 | 0.85 % | $ 3.8 B | USA |
 |
West Pharmaceutical Services
WST
|
301 M | - | - | $ 22.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 10.21 | 2.82 % | $ 2.04 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 25.89 | 1.29 % | $ 1.74 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.71 | 5.46 % | $ 21.3 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 63.52 | 1.45 % | $ 209 M | USA |
 |
Predictive Oncology
POAI
|
10.3 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 23.95 | -3.19 % | $ 1.14 B | USA |
 |
Stereotaxis
STXS
|
39.2 M | - | - | $ 175 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 19.18 | 0.79 % | $ 9.84 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 208.05 | -0.45 % | $ 30.4 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 28.29 | -1.84 % | $ 1.35 B | USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 5.59 | 1.27 % | $ 248 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 11.92 | -0.33 % | $ 487 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 147.63 | 0.94 % | $ 42.5 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.47 | -5.96 % | $ 36.8 M | USA |
 |
OraSure Technologies
OSUR
|
120 M | $ 3.61 | 9.73 % | $ 265 M | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 115.06 | 1.49 % | $ 6.47 M | USA |